CONTINUING RESEARCH COLLABORATIONS |
|
Prof. Robert Unwin (Nephrology & Physiology,UCL) |
Purinergic signalling in kidney |
Prof. Jean-Pierre Timmermans (Department Tandheelkunde, EmbryologieWeefselleer en Ontleedkunde, University of Antwerp) |
Purinergic signalling in lung. |
Dr. Linda Greensmith (Institute of Neurology) |
Motor Neurone Disease. |
Dr. Lori Birder & Prof. Chet de Groat (Renal Division, Department of Medicine
University of Pittsburgh, Philadelphia) |
Purineregic signalling in lower urinary tract |
Dr. Fred Mendelsohn (Howard Florey Institute, Melbourne) |
Neurodegenerative diseases |
Dr. Tim Arnett (Anatomy, UCL) |
Purinergic signalling in bone |
Prof. Maria Abbracchio (Institute of Pharmacological Sciences, Milan) |
Purinergic signalling in astroycytes |
Dr. Ken Jacobson (NIH, Bethesda) |
Medicinal chemistry of selective purinoceptor agonistsand antagonists |
Prof. Joe Neary (Department of Veterans Affairs, Medical Center, Miami) |
Purinergic signalling -second messenger pathways. |
Dr. David Erlinge (Lund, Sweden) and Prof. Dimitri Mikhailides (Chemical Pathology, Royal Free) |
P2 receptors and platelets. |
Prof. David Grundy and Dr. Weifang Rong (University of Sheffield) |
P2X receptor knockout mice and gut physiology |